Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 27, 2016
MD Biosciences has announced the addition of its suite of in vivo and in vitro cancer models to its family of preclinical contract research services.
read more
Tuesday, January 26, 2016
Medidata a global provider of cloud-based solutions for clinical research in life sciences, announced that ONO Pharmaceutical Co., Ltd. (“ONO”) has expanded its adoption of the Medidata Clinical Cloud® to include all clinical trials testing the use ...
read more
Tuesday, January 26, 2016
Broad Institute Genomic Services has partnered with Takeda Pharmaceutical Company Limited to perform genomic analysis on patient samples from a Phase 3 clinical trial of NINLARO® (ixazomib), an oral proteasome inhibitor that was recently approved by ...
read more
Tuesday, January 26, 2016
ClinTec International has announced the appointment of Dr Robert Reekie as Chief Operating Officer (COO) & Senior Executive Vice President, as it continues to demonstrate strong growth and international expansion.
read more
Tuesday, January 26, 2016
Aeterna Zentaris Inc. has filed an international patent application as well as national patent applications in selected countries including the US, China, Taiwan, Japan and India. These applications seek to protect the novel method of manufacturing ...
read more
Piramal Critical Care, an integral business unit of Piramal Enterprises Limited and Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology, have officially launched a co-promotion of ...
read more
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive...
read more
Recipharm has announced the appointment of Anke Mollowitz to the role as Key Account Director. Anke has joined the Business Management team and is responsible for coordinating customer management and commercial aspects, as well as developing ...
read more
Thursday, January 21, 2016
AMRI has announced that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016. Ms. Von Rohr will report to George Svokos, Chief Operating Officer, and will be a member of the executive team led by President and Chief...
read more
Thursday, January 21, 2016
Biovest International Inc. announced that it will spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named “Cell Culture Company, LLC.” Cell Culture Company will supply automated single-use perfusion ...
read more
Thursday, January 21, 2016
Averica Discovery, an analytical development contract research organization (CRO) with specialized expertise in small molecule analysis and purification, has announced the appointment of Cynthia Berger, Ph.D., to the newly-created position of Vice ...
read more
Wednesday, January 20, 2016
Cognition Life Science, Inc. has selected Smart Science Laboratories Inc. as an FDA/GMP manufacturer for the production of its product for sleep disorders.
read more
Wednesday, January 20, 2016
Catalent Pharma Solutions has announced that it is to introduce clinical supply services at its 200,000 sq. ft. cGMP facility in Kakegawa, Japan.
read more
Wednesday, January 20, 2016
AMPAC Fine Chemicals LLC has announced the appointment ofAslam Malik, Ph.D., to the position of President and Chief Executive Officer (CEO) effective January 1, 2016.
read more
Wednesday, January 20, 2016
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), announced that it entered into a new agreement for the cGMP manufacturing of UCART123 clinical batches, Cellectis’ lead product ...
read more